Management of COVID ARDS: Highlighting the knowledge Gap among Pediatricians
Abstract
Abstract Views: 20
To find out the gaps in the knowledge among pediatricians regarding the management of COVID ARDS. Cross-sectional descriptive study. Online survey was done through social media apps over the period of 2 months.
Data was collected through a predesigned questionnaire that was circulated to Pediatrician electronically through social media. 147 doctors submitted their response; the Majority were females (65.3%); respondents
include different cadres of doctors including consultants (32.7%), postgraduate trainees (40.7%) and medical officers (26.5%). COVID knowledge score was obtained by the number of correct answers to 18 selected questions and it was 11.18 ± 2.35. Postgraduate trainees and those who are working in government hospitals have better knowledge scores as compared to others (p-value <0.05). Several areas of concern were revealed particularly only 34.7 % have the knowledge about in-line suction, 22.4 % have the expertise in video laryngoscopy, 42.9 % know that lower tidal volume ventilation should be done in COVID ARDS patients and only
12.2 % know that lower pH values are acceptable in such patients. 51 % of the respondents have been trained or attended courses on the management of COVID-19 patients and only 53 % feel comfortable managing pediatric
COVID-19 patients. This study demonstrates an urgent need for awareness and training activities regarding the management of COVID-19 pneumonia and ARDS patients and about the protective measures in performing the
procedures on such patients.
Downloads
References
. Sahin AR, Erdogan A, Agaoglu PM, et al. 2019 novel coronavirus (COVID-19) outbreak: A review of the current literature. Eurasian J Med Oncol. 2020;4(1):1–7. https://doi.org/10.14744/ejmo.2020.12220
Xu Z, Shi L, Wang Y, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020;8(4):420–422. https://doi.org/10.1016/S2213-2600(20)30076-X
Fan E, Beitler JR, Brochard L, et al. COVID-19-associated acute respiratory distress syndrome: Is a different approach to management warranted? Lancet Respir Med. 2020;8(8):816–821. https://doi.org/10.1016/S2213-2600(20)30304-0
Wu C, Chen X, Cai Y, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med. 2020;180(7):934–943. https://doi.org/10.1001/jamainternmed.2020.0994
Gibson PG, Qin L, Puah SH. COVID‐19 acute respiratory distress syndrome (ARDS): Clinical features and differences from typical p re‐COVID‐19 ARDS. The Medical Journal of Australia. 2020;213(2):54–56. https://doi.org/10.5694/mja2.50674
Murthy S, Gomersall CD, Fowler RA. Care for critically Ill patients with COVID-19. JAMA. 2020;323(15):1499–1500. https://doi.org/10.1001/jama.2020.3633
World Health Organization. Management of critical COVID-19: Acute respiratory distress syndrome (ARDS). https://www.who.int/docs/default-source/coronaviruse/clinical-management-of-covid-19_acute-hypoxaemic-respiratory-failure-and-covid-19.pdf?sfvrsn=385c33c8_1&download=true
Anesi GL. COVID-19: Management of the intubated adult. UpToDate. Mar 14, 2023. https://www.uptodate.com/contents/coronavirus-disease-2019-covid-19-critical-care-and-airway-management-issues#H799885903. Accessed December 4, 2020.
Kache S, Chisti MJ, Gumbo F, et al. COVID-19 PICU guidelines: For high- and limited-resource settings. Pediatr Res. 2020;88:705–716. https://doi.org/10.1038/s41390-020-1053-9
Marini JJ, Gattinoni L. Management of COVID-19 respiratory distress. JAMA. 2020;323(22):2329–2330. https://doi.org/10.1001/jama.2020.6825
Khan NA, Akhtar J. Respiratory and ventilator management of COVID-19. J Pak Med Assoc. 2020;70(5):S60–S63. https://doi.org/10.5455/jpma.23
Pediatric acute respiratory distress syndrome: Consensus recommendations from the pediatric acute lung injury consensus conference. Pediatr Crit Care Med. 2015;16(5):428–439. https://doi.org/10.1097%2FPCC.0000000000000350
Dobler CC, Murad MH, Wilson ME. Noninvasive positive pressure ventilation in patients with COVID-19. Mayo Clin Proc. 2020;95(12):2594–2601. https://doi.org/10.1016/j.mayocp.2020.10.001
Chanques G, Constantin JM, Devlin JW, et al. Analgesia and sedation in patients with ARDS. Intensive Care Med. 2020;46:2342–2356. https://doi.org/10.1007/s00134-020-06307-9
Pruett W, Morrow LE, Malesker MA. Pharmacotherapy considerations in hospitalized patients with COVID-19 pneumonia. US Pharm. 2020;45(7/8):HS9–HS16.
Sheikh S, Baig MA. Optimising ventilator use during the COVID-19 pandemic. J Coll Physicians Surg Pak. 2020;30(6):S46–S47. https://doi.org/10.29271/jcpsp.2020.Supp2.S46
Zheng H, Li S, Sun R. Clinical experience with emergency endotracheal intubation in COVID-19 patients in the intensive care units: A single-centered, retrospective, descriptive study. Am J Transl Res. 2020;12(10):6655–6664.
Beigel JH, Tomashek KM, Dodd LE, et al. Remdesivir for the treatment of COVID-19 - final report. N Engl J Med. 2020;383(19):1813–1836. https://doi.org/10.1056/NEJMoa2007764
Recovery Collaborative Group, Horby P, Lim WS, et al. Dexamethasone in hospitalized patients with COVID-19 - preliminary report. N Engl J Med. 2021;384:693–704. https://doi.org/10.1056/NEJMoa2021436
COVID 19 Treatment Guidelines. https://www.covid19treatmentguidelines.nih.gov/whats-new/. Accessed December 24, 2020.
Guaraldi G, Meschiari M, Lepri AC et al. Tocilizumab in patients with severe COVID-19: A retrospective cohort study. Lancet Rheumatol. 2020;2(8):e474–e484. https://doi.org/10.1016/S2665-9913(20)30173-9
Dastan F, Saffaei A, Haseli S. Promising effects of tocilizumab in COVID-19: A non-controlled, prospective clinical trial. Int Immunopharmacol. 2020;88:e106869. https://doi.org/10.1016/j.intimp.2020.106869
Salvarani C, Dolci G, Massari M, et al. Effect of tocilizumab vs standard care on clinical worsening in patients hospitalized with COVID-19 pneumonia: A randomized clinical trial. JAMA Intern Med. 2021;181(1):24–31. https://doi.org/10.1001/jamainternmed.2020.6615
Parr JB. Time to reassess Tocilizumab’s role in COVID-19 pneumonia. JAMA Intern Med. 2021;181(1):12–15. https://doi.org/10.1001/jamainternmed.2020.6557
Son MB, Friedman K. Coronavirus disease 2019 (COVID-19): Multisystem inflammatory syndrome in children (MIS-C) management and outcome. UpToDate. June 29, 2022. https://www.uptodate.com/contents/coronavirus-disease-2019-covid-19-multisystem-inflammatory-syndrome-in-children-mis-c-management-and-outcome. Accessed December 28, 2020.
Copyright (c) 2022 Umer Waqar Azeem, Nighat Sultana, Muhammad Sarwar, Zarafsheen Khalid
This work is licensed under a Creative Commons Attribution 4.0 International License.
